After pilot testing, the questionnaire was subjected for field testing on 300 consecutive PWP from the the same institution. Demographics, per capita monthly income (PCMI) and Levodopa equivalent daily dosage (LEDD) of these PWP were recorded. In addition to the questionnaire, all participants were requested to fill either PDQ-39 [5] or 36-item short-form scale (SF-36). [18] PDQ-39 is most commonly used PD specific scale to assess HRQoL in PWP. PDQ-39 contains 8 domains: Mobility, Activities of daily living, Emotional well being, Stigma, Social support, Cognitions, Communication and Bodily discomfort. Items of PDQ-39 assess how often PWP experiences difficulty using 5 point ordinal range where 0 means never and 4 means always. Each domain provides a domain score ranging from 0 to 100. Lower score reflects better QoL. SF-36 is most commonly used generic HRQoL for PWP that contains 36 items in 8 subscales: Physical function (PF), role physical (RP), bodily pain (BP), general health (GH), vitality (VT), social function (SF), role emotion (RE) and mental health (MH). For each subscale, items are coded, summed and transformed on to a scale from 0 (worst HRQoL) to 100 (Best HRQoL) using a software provided by Optum ® outcomes. SF-36 also provides two summary scores viz. Physical component summary score (PCS) and Mental component summary score (MCS) . Scores are norm based: mean (SD) = 50 (10) . Score interpretation: 50 is average; 0 to 49 are below average and 51 to 100 are above average (higher the score better will be QOL).
Proxies were used for collection of response in participants in advanced stage, who could not respond reliably due to infirmity/severe tremor. Questionnaires were reviewed for missing responses and participants were encouraged to answer all items before leaving.
Item reduction and construction of scales
Item-level analysis of data from field testing was done to find floor and ceiling effects and mean response of each item. We calculated impact of each item by multiplying mean response of the item with frequency of that item. Exploratory factor analysis of 68 items was done. Domains with eigenvalue >1 were retained and subjected to maximum likelihood method, followed by orthogonal varimax rotation to improve loading of items around domains. Items that loaded more than 0.4 were considered relevant. Before dropping an item, the remaining items were reviewed in relation to content validity of the questionnaire. The fate, frequency, mean response, and impact of all 68 items have been shown in Appendix 1. Extracted domains were subjected to confirmatory factor analysis to assign subscales. These subscales and global QoL item constituted QLPD [Appendix 2]. Cronbach's alpha (α) and item-scale correlation were used for internal consistency. Subscale scores and summary score were created on 0-100 scale with higher score representing poor HRQoL as follows: 1. Subscale score = aggregate of observed scores of items in the subscale/maximum possible total score of that subscale × 100 2. Summary score = aggregate of observed scores of items in all subscales/maximum possible total score of all subscale × 100.
Single-item QoL scales are valid and reliable tool for measuring QoL, [19, 20] so considering global QoL, a close approximation of true QoL, we did intraclass correlation (ICC) between summary score and global QoL score. For discriminative validity, we compared mean summary score and subscale scores for five categories of participants on the basis of global QoL (0-20, very bad; 21-40, bad; 41-60, neither good nor bad; 61-80, good; and 81-100, very good) using one-way analysis of variance. Multitrait-multimethod correlation matrix was used for convergent and divergent (discriminant) validity of QLPD subscales with subscales of PDQ-39 and SF-36. We attributed strong correlation when Spearman's correlation coefficient (ρ) was ≥0.6 between two subscales, moderate correlation for 0.4 ≤ ρ < 0.6, while low correlation for ρ < 0.4. Strong correlation coefficients between similar subscales of QLPD and PDQ-39 and/ or SF-36 were considered evidence of convergent validity while divergent validity was assumed when a subscale of QLPD had the highest correlation with similar subscales of PDQ-39 and/or SF-36, i.e., lower correlation with other unrelated subscales of PDQ-39 and/or SF-36. We did regression analysis to determine the effect of demographics and clinical severity on HRQoL. For this purpose, we divided participants into two groups Group 
Results
Demographic summary of PWP who participated in the study is shown in Table 1 . Mean (range) clinical experience of nine interviewed specialists was 19.2 (8-32) years for treating PWP. The duration of interviews ranged from 15 to 45 min.
In the pilot testing of initial questionnaire, face validity and content validity of the questionnaire were graded as very good as the stakeholders did not suggest any new item. From 300 PWP for field testing, five treatment-naive persons were excluded from the study, as questions regarding treatment satisfaction and/or expenditure were irrelevant for them. Final analysis was done on data collected from 295 PWP. Out of 295 PWP, 136 also filled PDQ-39 scale while 114 filled SF-36 scale. Item-level analysis of data revealed that only 0.85% of data was missing which was replaced with item's mean value. [21] The mean response of all items was in the range of 0.18-2.88 (maximum possible = 4) while the impact of items ranged from 0.01 to 2.11 (maximum possible = 4). Exploratory factor analysis of 68 items yielded eight domains with eigenvalue >1 that accounted for 80.3% variance of the data. After applying maximum likelihood with eight domains and orthogonal varimax rotation, 41 items loaded >0.4 in seven domains. These domains were motor, financial, fear and social, psychological, NMS, treatment, and family with variance 46%, 10%, 6%, 5%, 4%, 3%, and 3%, respectively. None of the items in the 8 th domain reached benchmark of 0.4 and accounted for only 2.9% variance and so it was dropped.
Of the remaining 27 items with loading <0.4, 11 causal items on tremor, family disturbance, consistency of effects of medicine, constipation, fatigue, sleep, body aches, sensory symptoms, swallowing, restless leg syndrome, and sexual satisfaction were retained, as these do not follow psychometric principles. These 11 items were distributed among seven domains on the basis of their face validity. The remaining 16 items were deleted as they neither were causal items nor loaded >0.4. This left us with 52 items. To further reduce items, seven more items on social embarrassment, family responsibilities, spat in family, dependency on medication, vision-related problems, and weird dreaming were removed as they were either not applicable to large population, or their content was already represented in other items in different domains. Hence, the final questionnaire contained 45 items.
Confirmatory factor analysis of financial, psychological, treatment, and family domains revealed single dimensionality. Motor domain was divided into activities of daily living (ADL) and mobility domain. 'Fear and social' domain was divided into two separate social and fear domains. NMS domain did not show single dimensionality on confirmatory factor analysis as it consisted of causal items. We decided to retain all NMS items, though they did not comply with factor analysis and an item on overall health satisfaction into NMS domain. These nine domains formed nine subscales. Finally, we had 45 items in nine subscales plus one global QoL which constituted QLPD [Appendix 2].
Internal consistency (reliability) and scoring of quality of life in Parkinson's disease
Cronbach's alpha (α) of QLPD was 0.94 while α of eight subscales was in the range of 0.74-0.91 [ Table 2 ]. Item-scale correlations of subscales found only four items that did not correlate with their subscales as α improved after removing these items. These four items were retained considering content validity. Subscale scores were widely distributed and had full range of scores from 0 to 100 in all subscales except NMS (0-86) [ Table 2 ]. Mean (standard deviation [SD], range) Table 3 ].
Multitrait-multimethod correlation matrix showed good convergent and divergent validity. Table 4 shows the Spearman's correlation coefficient among subscales of the QLPD (n = 295), QLPD versus SF-36 (n = 114), and QLPD versus PDQ-39 (n = 136). For convenience, the subscales of QLPD and PDQ-39 were prefixed with q and p, respectively. 
dIscussIon
We developed QLPD instrument, a disease-specific HRQoL instrument for Hindi-speaking Indian PD population. From literature review and interviews of stakeholders involved in the care of PWP, comprehensive coverage of all relevant items related to HRQoL was ensured, but item reduction was a challenge. It was difficult to ascertain the cutoff line for inclusion of items on the basis of impact. Second, many items on NMS and falls had low impact due to the lower prevalence in our population due to the differential representation of various stages, but when present, they significantly and adversely affected QoL. Keeping content validity in mind, clinimetrics based on clinical sensibility; and psychometrics based on factor analysis guided us to finalize items. We made it a point to include patients of varied background and all severity of disease, so that the instrument would be relevant to all categories of Indian PWP. Our sample for field testing was a heterogeneous group of PWP, including persons of both gender, wide age range (23-85 years), wide duration of illness (3 months-32 years), and wide severity of PD as gauged by H and Y stage of disease (1) (2) (3) (4) (5) .
QLPD is comprehensive in approach with all relevant domains of HRQoL in PWP. QLPD gives emphasis on NMS in addition to motor function as it has 13 items on NMS while 10 items on motor functions. This makes it more relevant and holistic as it takes in account both motor and NMS to measure QoL, since past studies [22] [23] [24] have shown higher impact of NMS on HRQoL.
Treatment and finance are two unique subscales in QLPD. Successful management of symptoms and meeting the patients' expectations has direct relationship with patients' HRQoL. [25] Regularly, new technologies [26] for the management of PD are emerging. HRQoL has been recommended as an important end point for efficacy measurement of any new treatment strategy; [27] therefore, it is required that PD-specific HRQoL instruments should be sensitive to treatment efficacy as well as patients' satisfaction. Financial implication of the disease is of paramount importance for PWP, especially in low-income countries in the absence of medical insurance. The direct cost of treatment due to expenditure on medications, consultations, and visits to the hospital as well as indirect costs in the form of loss of wages of self and caregiver also impact overall well-being. [2] Lower PCMI was found to be associated with poor HRQoL in this study. Similar results have been published by Ray et al. [28] We chose 5-point Likert scale as it covers good range of possible responses with adequate scope for change in score with change in status of the patient while keeping a balance between precision and responsiveness. [29] To develop subscale scores and summary score, we did not use weights as it has not been shown to be better method than nonweighted system. [30] The internal consistency of QLPD and its subscales except treatment subscale was very good. Low internal consistency of treatment subscale may be attributed to its three items with wide-ranging content. The presence of ceiling or floor effects indicates that scale will have poor discrimination resulting in reduced sensitivity and responsiveness. [29] Summary score and Validity of a scale implies ability of the scale to measure what it intends to measure. An ICC of 0.79 between global QoL and summary score in QLPD supports the patient's overall perceived QoL which is highly correlated with estimated QoL from nine subscales. Interpretability of the QLPD is good as it provides a scale profile on 0-100 scales that includes a summary score, nine subscale scores, and one global QoL item.
Construct validity of quality of life in Parkinson's disease and its subscales
The convergent validity of QLPD's subscales with similar subscales and divergent validity with unrelated subscales of SF-36 and PDQ-39 were good. ADL subscale of QLPD had high correlation with mobility, family and NMS subscales of QLPD, and ADL and mobility subscales of PDQ-39. High correlation between ADL and mobility subscales may be attributed to items of these subscales which are largely motor features whereas high correlation between ADL and NMS subscales of QLPD may be due to parallel deterioration of motor as well as NMS with advancing disease. Fulfilling family responsibilities largely depends on patient's ability to move and ability to do household chores and/or occupational works that are primarily dependent on physical abilities that may explain high correlation of ADL subscale with family subscale. Psychological subscale of QLPD has high correlation with emotion subscale of PDQ-39, mental health, and mental component summary of SF-36 that primarily consists of items on anxiety and depression, hence highly correlated to each other. Fear subscale of QLPD had high correlation with emotion and stigma subscales of PDQ-39 and mental health subscale of SF-36. Patients who are apprehensive and worrying in nature (neuroticism trait) [31] curtail their social participation affecting their social life. The common elements among these subscales were fearfulness, worrying nature, stigma, and emotional issues.
Treatment and finance subscales contributed around 14% of total variability in the data and had low-to-very low correlations with most of the subscales of QLPD, PDQ-39, and SF-36. The items of these two subscales are unique and are not available in other scales. In QLPD, global QoL item is moderately (0.4-0.6) correlated with all subscales of QLPD which suggests that all subscales of QLPD contribute to overall QoL in PD.
The development of QLPD had many limitations and challenges. Being a single-center study has its own strength, as it ensures uniformity of data collection and assessment. The number of participants in Stage 5 was low (3%) as patients who are very disabled do not like to visit hospitals due to obvious reason. This was observed in many of the studies published earlier. [22, 28] Despite these limitations, QLPD is the first disease-specific HRQoL instrument that has been developed after defining HRQoL and conceptualization of QoL and does not measure just frequency and severity of different symptoms but actually measures the perception of persons about impact of the disease on their lives. QLPD is an improvement over other known HRQoL questionnaires as it has finance, treatment, family, and NMS subscales that have not been considered in earlier PD-specific scales. QLPD also includes global QoL item that is instrumental in estimation of patient's self-perception about his/her overall QoL.
conclusIon
We have developed QLPD, a new HRQoL instrument for Hindi-speaking PWP. QLPD has good internal consistency, construct validity, precision of scores, and interpretability. It will be useful if it can be translated into other Indian languages and tested in PWP conversant with those languages. The 
Appendix 1: Item pool and global quality of life

